Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Basic) (2016 - 2025)

Fortress Biotech has reported EPS (Basic) over the past 13 years, most recently at -$0.23 for Q4 2025.

  • Quarterly results put EPS (Basic) at -$0.23 for Q4 2025, up 11.54% from a year ago — trailing twelve months through Dec 2025 was -$0.08 (up 97.13% YoY), and the annual figure for FY2025 was -$0.07, up 97.4%.
  • EPS (Basic) for Q4 2025 was -$0.23 at Fortress Biotech, down from $0.13 in the prior quarter.
  • Over the last five years, EPS (Basic) for FBIO hit a ceiling of $0.5 in Q2 2025 and a floor of -$4.82 in Q4 2022.
  • Median EPS (Basic) over the past 5 years was -$0.43 (2025), compared with a mean of -$1.08.
  • Biggest five-year swings in EPS (Basic): tumbled 1552.38% in 2023 and later skyrocketed 168.49% in 2025.
  • Fortress Biotech's EPS (Basic) stood at -$0.38 in 2021, then plummeted by 1168.42% to -$4.82 in 2022, then surged by 89.0% to -$0.53 in 2023, then surged by 50.94% to -$0.26 in 2024, then rose by 11.54% to -$0.23 in 2025.
  • The last three reported values for EPS (Basic) were -$0.23 (Q4 2025), $0.13 (Q3 2025), and $0.5 (Q2 2025) per Business Quant data.